UNH Stock Ownership Activity

UNITEDHEALTH GROUP INC 13F holders

14 value investing gurus have made changes to the UNITEDHEALTH GROUP INC (UNH) position according to the gurus' latest SEC quarterly report(s). UNH has been bought (as a new position) by 1, completely sold out by 2 guru(s), the number of UNH shares has been increased by 5, decreased by 6 super investor(s).

Which gurus or hedge funds are buying UNH now?

According to the latest SEC filing(s) UNITEDHEALTH GROUP INC (UNH) has been bought by 6 gurus, out of those top 5 purchases (by % change to portfolio) have been made by David Tepper - Appaloosa Management (added shares +33.33%), Eric H. Schoenstein - Jensen Investment Management (added shares +1.2%), Andrew R. Adams - Mairs & Power Growth Fund (added shares +1.78%), V. D. Dodge, E. M. Cox - Dodge & Cox Stock Fund (added shares +0.37%) and Robert Olstein - Olstein Capital Management (added shares +31.82%).

To see more about who is investing in UNITEDHEALTH GROUP INC (UNH), please go to the UNH ownership page.

2023 Q2 (14 results)
David Katz
buy
+730
+0.62%
0.62%
David Tepper
+33.33%
+50,000
+0.45%
1.78%
Robert Olstein
+31.82%
+3,500
+0.27%
1.13%
Andrew R. Adams
+1.78%
+9,000
+0.09%
5.08%
Eric H. Schoenstein
+1.20%
+16,143
+0.06%
4.80%
V. D. Dodge, E. M. Cox
+0.37%
+8,300
+0.00%
1.20%
Ronald Muhlenkamp
-0.10%
-25
-0.00%
4.21%
David M. Polen
-2.08%
-56,360
-0.07%
3.17%
David Rolfe
-2.41%
-1,811
-0.14%
5.69%
Ravenel Boykin Curry IV
-6.41%
-128,513
-0.28%
4.05%
Paul Lountzis
-7.23%
-902
-0.25%
3.26%
Ole Andreas Halvorsen
-14.56%
-305,716
-0.60%
3.54%
John Armitage
-100.00%
-89,364
-0.44%
0.00%
Daniel Loeb
-100.00%
-335,000
-2.32%
0.00%
Current price: $506.10 4.75% AVG reported price*: $483.16
2023 Q1 (12 results)
Ole Andreas Halvorsen
+65.65%
+832,288
+1.85%
4.68%
Robert Olstein
+41.94%
+3,250
+0.24%
0.81%
David Rolfe
+24.09%
+14,606
+1.17%
6.03%
Paul Lountzis
+7.03%
+819
+0.23%
3.49%
David M. Polen
-0.48%
-13,041
-0.02%
3.38%
Eric H. Schoenstein
-3.38%
-47,090
-0.17%
4.99%
Ravenel Boykin Curry IV
-8.26%
-180,603
-0.39%
4.32%
Glenn Greenberg
-8.29%
-100
-0.00%
0.02%
Stephen Mandel
-16.21%
-172,433
-0.75%
3.90%
Daniel Loeb
-50.00%
-335,000
-2.59%
0.00%
John Armitage
-91.60%
-974,662
-4.97%
0.00%
Francois Rochon
-100.00%
-1,733
-0.06%
0.00%
Current price: $506.10 7.14% AVG reported price*: $472.35
2022 Q4 (14 results)
Francois Rochon
buy
+1,733
+0.06%
0.00%
Ole Andreas Halvorsen
+263.71%
+919,153
+2.45%
3.38%
Eric H. Schoenstein
+15.38%
+185,736
+0.77%
5.78%
Stephen Mandel
+13.21%
+124,144
+0.63%
5.38%
Paul Lountzis
+0.13%
+15
+0.00%
3.33%
Ronald Muhlenkamp
+0.08%
+19
+0.00%
5.56%
David Rolfe
-0.40%
-245
-0.02%
5.90%
Andrew R. Adams
-1.56%
-8,000
-0.10%
6.20%
David M. Polen
-4.35%
-123,918
-0.19%
4.22%
V. D. Dodge, E. M. Cox
-6.15%
-148,300
-0.09%
1.39%
John Armitage
-7.44%
-85,473
-0.39%
4.85%
Robert Olstein
-10.92%
-950
-0.08%
0.64%
Ravenel Boykin Curry IV
-24.94%
-726,183
-1.83%
5.49%
Glenn Greenberg
-51.09%
-1,260
-0.02%
0.02%
Current price: $506.10 3.83% AVG reported price*: $526.25
2022 Q4 (1 result)
Ruane, Cunniff & Goldfarb
-17.06%
-79,350
-1.45%
7.03%
Current price: $506.10 4.54% Reported price*: $530.18
41 of 406

Shares, change to shares, sold shares - split-adjusted.

Reported price - this doesn't represent the actual buy or sell price.
It is the split-adjusted price of the security as of the last day of the reported period.

Value or Price - If the security is completely sold out, we show the reported value (or price) prior to the actual period.